Back to results
US 11,304,949 B2Granted
Treatment of hidradenitis suppurativa using JAK inhibitors
AssigneeIncyte Corporation
InventorsMichael D. Howell, Paul Smith
Life of this patent
Estimating the term…
Abstract
The present application provides methods of treating hidradenitis suppurativa in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound which inhibits JAK1 and/or JAK2, or a pharmaceutically acceptable salt thereof.
Claims17
A method of treating hidradenitis suppurativa in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound which is:
- 4[3-(cyanomethyl)-3-(3′,5′-dimethyl-1H,1′H-4,4′-bipyrazol-1-yl)azetidin-1-yl]-2,5-difluoro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.